Streetbeat News

Equity Actions

BCC

Boise Cascade (NYSE:BCC) received mixed analyst ratings over the past three months, with 2 bullish and 3 indifferent ratings. The average 12-month price target is $127.4, up from the previous $116.80. Analysts from Goldman Sachs and Truist Securities have adjusted their price targets and ratings, reflecting changes in market conditions and company performance. Boise Cascade operates in engineered wood products and building materials distribution, with the latter generating most revenue. Financial analysis shows a -14.86% revenue decline, a net margin of 7.8%, an ROE of 6.39%, an ROA of 4.02%, and a low debt-to-equity ratio of 0.22.

Portfolio Pulse from Benzinga Insights

January 11, 2024 | 4:01 pm

CE

Celanese (NYSE:CE) received mixed analyst ratings with 6 analysts offering their perspectives. The average 12-month price target is $156.17, up from $147.60, with a high of $176.00 and a low of $135.00. Analysts from UBS, Keybanc, Citigroup, Piper Sandler, and RBC Capital have adjusted their ratings and price targets. Celanese's financial performance shows strong revenue growth, net margin, ROE, and ROA, but a higher debt-to-equity ratio compared to the industry average.

Portfolio Pulse from Benzinga Insights

January 11, 2024 | 4:00 pm

HLNE

Hamilton Lane (NASDAQ:HLNE) has been analyzed by 4 analysts, showing a shift towards a more positive outlook with recent raises in price targets. The average 12-month price target is now $97.25, up 4.01% from the previous $93.50. Analysts from Morgan Stanley, JP Morgan, and Wells Fargo have raised their price targets, reflecting optimism about the company's performance. Despite a recent revenue decline of -17.28%, Hamilton Lane boasts a strong net margin of 33.1%, an ROE of 9.36%, and an ROA of 3.28%, with a low debt-to-equity ratio of 0.6.

Portfolio Pulse from Benzinga Insights

January 11, 2024 | 4:00 pm

SKWD

Skyward Specialty (NASDAQ:SKWD) received mixed analyst ratings with 3 bullish, 2 somewhat bullish, and 1 indifferent. The average 12-month price target is $37.0, up from $32.80, with a high of $40.00 and a low of $31.00. Analysts from Wolfe Research, BMO Capital, Raymond James, Piper Sandler, and Truist Securities have raised their price targets, reflecting positive market dynamics and company performance. Skyward Specialty's financials show a 47.71% revenue growth, a net margin of 9.08%, an ROE of 4.1%, an ROA of 0.77%, and a low debt-to-equity ratio of 0.24.

Portfolio Pulse from Benzinga Insights

January 11, 2024 | 4:00 pm

FMST

TMST

USAU

U.S. Gold Corp. (USAU) provided an update on its CK Gold Project, expecting permit approval and feasibility study completion in H1 2024, with the project being shovel-ready in H2 2024. The company anticipates environmental and economic benefits for Wyoming, and sees unrecognized asset value in Nevada and Idaho, with a positive market outlook for copper and gold. TimkenSteel (TMST) announced a rebranding to Metallus Inc., reflecting its growth commitment and vision for the future in the high-performance metals industry. Foremost Lithium (FMST) received a multi-year work permit for its Jean Lake Lithium/Gold Project, allowing for streamlined exploration and a 15-hole drilling program, aiming to advance resource development and enhance shareholder value.

Portfolio Pulse from Austin DeNoce

January 11, 2024 | 3:54 pm

CMND

Clearmind Medicine Inc (NASDAQ:CMND) shares plummeted by 45% to $1.61 after announcing a registered direct offering at $1.60 per unit, totaling approximately $2.4 million. The offering includes 1.5 million Common Units, each consisting of Common Shares or Pre-Funded Warrants, and PIPE Common Warrants. The Pre-Funded Warrants are immediately exercisable, while the PIPE Common Warrants expire in 60 months. The proceeds are aimed at general corporate purposes and working capital. CMND's 52-week trading range is between $2.04 and $210.00.

Portfolio Pulse from Henry Khederian

January 11, 2024 | 3:49 pm

SRE

BMO Capital Markets analyst James Thalacker upgraded Sempra (NYSE:SRE) from Market Perform to Outperform and raised the price target from $76 to $84. Sempra is recognized for its above-average earnings growth, strong balance sheet, and capable leadership. The company's earnings growth through 2026 is expected to be driven by its regulated utility investment program, with a 5-year investment plan likely reaching the upper end of its $44-48 billion outlook. Sempra recently completed a $1.4 billion equity offering to secure funding for its 2024-2028 capital program.

Portfolio Pulse from Priya Nigam

January 11, 2024 | 3:20 pm

CHK

SWN

Chesapeake Energy (CHK) has announced a merger with Southwestern Energy (SWN), expected to be completed in Q2 of 2024. CHK will give SWN $7.40 billion in stock in exchange for SWN stock. Both companies are US-based and involved in the exploration and production of oil, natural gas, and natural gas liquids.

Portfolio Pulse from Benzinga Insights

January 11, 2024 | 3:10 pm

SCHW

Arkansas Representative French Hill sold Charles Schwab (NYSE:SCHW) stock valued between $50,001 and $100,000 on January 10, 2024. The sale was reported in a Periodic Transaction Report. While Congressional transactions can be a consideration for investors, they are not a primary factor for investment decisions. The STOCK Act prohibits Congress members from using non-public information for personal gain in stock transactions.

Portfolio Pulse from Benzinga Insights

January 11, 2024 | 3:05 pm

WSM

11 analysts have recently updated their ratings on Williams-Sonoma (NYSE:WSM), with a mix of bullish, neutral, and bearish sentiments. The average 12-month price target is now $167.36, up 21.18% from the previous $138.11, with a high estimate of $230.00 and a low of $140.00. Analysts from firms like Wedbush, Evercore ISI Group, RBC Capital, UBS, JP Morgan, Goldman Sachs, Morgan Stanley, Telsey Advisory Group, and Jefferies have adjusted their price targets and ratings, reflecting a positive shift in expectations. Williams-Sonoma operates in the home category market and has shown strong net margins and ROE, but its revenue growth has declined by -15.46% over the past 3 months.

Portfolio Pulse from Benzinga Insights

January 11, 2024 | 3:01 pm